Lkb1 Loss Promotes Tumor Progression of BRAFV600E-Induced Lung Adenomas

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  González Sánchez, Elena ^a   Martín Caballero, Juan ^b   Flores, Juana María ^c   Hernández Losa, Javier ^d   Montero, Ma Ángeles ^e   Cortés, Javier ^f   Mares, Roso ^d   Barbacid, Mariano ^g   Recio, Juan A ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Barcelona Biomedical Research Park   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^f VALL D HEBRON UNIVERSITY HOSPITAL   (Spain)

^g Centro Nacional de Investigations Oncológicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; PROTEIN KINASE LKB1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAF GENE; CELL POPULATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE ACTIVITY; GENE FUNCTION; GENE LOSS; GENE MUTATION; LKB1 GENE; LUNG ADENOMA; LUNG ALVEOLUS CELL; MOUSE; NEWBORN; NONHUMAN; ONCOGENE; RISK FACTOR; SENESCENCE; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ADENOMA; ANIMALS; ANIMALS, NEWBORN; CADHERINS; CARCINOGENESIS; DISEASE PROGRESSION; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; MICE, TRANSGENIC; MUTATION; ONCOGENES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS B-RAF; PULMONARY SURFACTANT-ASSOCIATED PROTEIN C; TAMOXIFEN; TUMOR SUPPRESSOR PROTEIN P53;

MUS;

EID: 84879383838     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066933     Document Type: Article

References (26)

1. Brose MS, Volpe P, Feldman M, Kumar M, Rishi I, et al. (2002) BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res 62: 6997-7000.
2. Naoki K, Chen TH, Richards WG, Sugarbaker DJ, Meyerson M, (2002) Missense mutations of the BRAF gene in human lung adenocarcinoma. Cancer Res 62: 7001-7003.
3. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417: 949-954.
4. Pao W, Miller V, Zakowski M, Doherty J, Politi K, et al. (2004) EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci U S A 101: 13306-13311.
5. Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, et al. (2001) Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15: 3243-3248.
6. Guerra C, Mijimolle N, Dhawahir A, Dubus P, Barradas M, et al. (2003) Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 4: 111-120.
7. Dankort D, Filenova E, Collado M, Serrano M, Jones K, et al. (2007) A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. Genes Dev 21: 379-384.
8. Haigis KM, Wistuba, II, Kurie JM, (2007) Lung premalignancy induced by mutant B-Raf, what is thy fate? To senesce or not to senesce, that is the question. Genes Dev 21: 361-366.
9. Lundin A, Driscoll B Lung cancer stem cells: Progress and prospects. Cancer Lett.
10. Kotton DN, Fine A, (2008) Lung stem cells. Cell Tissue Res 331: 145-156.
11. Chen H, Matsumoto K, Stripp BR, (2009) Bronchiolar progenitor cells. Proc Am Thorac Soc 6: 602-606.
12. Rock JR, Onaitis MW, Rawlins EL, Lu Y, Clark CP, et al. (2009) Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc Natl Acad Sci U S A 106: 12771-12775.
13. Sanchez-Cespedes M, Parrella P, Esteller M, Nomoto S, Trink B, et al. (2002) Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res 62: 3659-3662.
14. Gill RK, Yang SH, Meerzaman D, Mechanic LE, Bowman ED,et al. Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer. Oncogene 30: 3784-3791.
15. Liu W, Monahan KB, Pfefferle AD, Shimamura T, Sorrentino J,et al. LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma. Cancer Cell 21: 751-764.
16. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, et al. (2005) Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121: 823-835.
17. Shackelford DB, Abt E, Gerken L, Vasquez DS, Seki A,et al. LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin. Cancer Cell 23: 143-158.
18. Shah U, Sharpless NE, Hayes DN, (2008) LKB1 and lung cancer: more than the usual suspects. Cancer Res 68: 3562-3565.
19. Ji H, Ramsey MR, Hayes DN, Fan C, McNamara K, et al. (2007) LKB1 modulates lung cancer differentiation and metastasis. Nature 448: 807-810.
20. Downward J, (2006) Signal transduction. Prelude to an anniversary for the RAS oncogene. Science 314: 433-434.
21. Dankort D, Curley DP, Cartlidge RA, Nelson B, Karnezis AN, et al. (2009) Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet 41: 544-552.
22. Battyani Z, Xerri L, Hassoun J, Bonerandi JJ, Grob JJ, (1993) Tyrosinase gene expression in human tissues. Pigment Cell Res 6: 400-405.
23. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, et al. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436: 720-724.
24. Carretero J, Medina PP, Pio R, Montuenga LM, Sanchez-Cespedes M, (2004) Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene. Oncogene 23: 4037-4040.
25. Matsumoto S, Iwakawa R, Takahashi K, Kohno T, Nakanishi Y, et al. (2007) Prevalence and specificity of LKB1 genetic alterations in lung cancers. Oncogene 26: 5911-5918.
26. Esteve-Puig R, Canals F, Colome N, Merlino G, Recio JA, (2009) Uncoupling of the LKB1-AMPKalpha energy sensor pathway by growth factors and oncogenic BRAF. PLoS One 4: e4771.